Ascendis Pharma A/S - ASND

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 6.0% 3,719,452 View
May 14, 2026 SCHEDULE 13G/A Capital International Investors 3.2% 2,013,285 View
May 07, 2026 SCHEDULE 13G/A T. Rowe Price Investment Management, Inc. 10.5% 6,506,219 View
May 07, 2026 SCHEDULE 13G T. Rowe Price Investment Management, Inc. 9.9% 6,162,042 View
May 06, 2026 SCHEDULE 13G/A FMR LLC 6.6% 3,852,101 View
May 06, 2026 SCHEDULE 13G/A Abigail P. Johnson 6.6% 3,852,101 View
Feb 11, 2026 SCHEDULE 13G/A Westfield Capital Management Company, L.P. 8.48% 5,185,696 View
Feb 03, 2026 SCHEDULE 13G/A Artisan Partners Asset Management Inc. 5.2% 3,225,885 View
Feb 03, 2026 SCHEDULE 13G/A Artisan Partners Holdings LP 5.2% 3,225,885 View
Feb 03, 2026 SCHEDULE 13G/A Artisan Investments GP LLC 5.2% 3,225,885 View
Feb 03, 2026 SCHEDULE 13G/A Artisan Partners Limited Partnership 5.2% 3,225,885 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.